AzTrials
AzTrials

Periodontal Attachment LossNCT06003322

Non - Incised Papilla Versus Single Flap Technique In The Reconstruction Of Intrabony Defect

A study testing non - Incised Papilla surgical approach NIPSA for intrabony defect and single-flap approach SFA in people with Periodontal Attachment Loss, run by Ain Shams University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The present study will aim to assess the effectiveness of the non-Incised Papilla surgical approach NIPSA used for the surgical debridement of deep intraosseous defects compared to the single-flap approach SFA. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Periodontal Attachment Loss
What is being tested?
non - Incised Papilla surgical approach NIPSA for intrabony defect and single-flap approach SFA
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteEgypt
Study dates
7 Aug 2023to 7 Sep 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • - Age > 18 years
  • Diagnosis with stage III-IV periodontitis.
  • Presence of one or more intrabony defects with probing pocket depth (PPD) > 5 mm and radiographic defect depth > 4 mm.
  • Full-mouth plaque score (FMPS) and full-mouth bleeding score (FMBS) < 30% (measured at four sites per tooth).
  • No relevant systemic condition or disease.

Who cannot join

  • Third molars and teeth with type III mobility or with an incorrect endodontic or restorative treatment.
  • -

Trial locations and contacts

1 site in 1 country.

Egypt1 site, 1 recruiting
  • faculty of dentistry ,Assiut university

    Asyut, 23145

    Alaa Ali, Ph.D., 01003646556, alaa.ali@dent.aun.edu.eg

    Aya Ali, Ph.D.

    Recruiting

Other trials in Egypt

About this study

Official title: Non - Incised Papilla Versus Single Flap Technique In The Reconstruction Of Intrabony Defect: a Randomized Controlled Trial

The present study will aim to assess the effectiveness of the non-Incised Papilla surgical approach NIPSA used for the surgical debridement of deep intraosseous defects compared to the single-flap approach SFA.

Primary outcome: interproximal clinical attachment level gain Secondary outcomes: residual probing pocket depth (PPD), pocket depth (PD) reduction, recession (REC), location of the tip of the papilla (TP), width of the keratinized tissue (KT), wound closure (WC), supra-alveolar attachment gain (SUPRA-AG)

Read the detailed description

The present study will aim to assess the effectiveness of the non-Incised Papilla surgical approach NIPSA used for the surgical debridement of deep intraosseous defects compared to the single-flap approach SFA.

Primary outcome: interproximal clinical attachment level gain Secondary outcomes: residual probing pocket depth (PPD), pocket depth (PD) reduction, recession (REC), location of the tip of the papilla (TP), width of the keratinized tissue (KT), wound closure (WC), supra-alveolar attachment gain (SUPRA-AG)

Being tested
non - Incised Papilla surgical approach NIPSA for intrabony defect, single-flap approach SFA
Medical subject headings
Periodontal Attachment Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • non - Incised Papilla surgical approach NIPSA for intrabony defectProcedure or surgery

    As described by Rodríguez and Caffesse in 2018, a single incision apical to the defect ,on the buccal aspect, only one apical horizontal or oblique incision will be made in the alveolar mucosa, as far removed as possible from the interdental papillae and marginal keratinized tis- sues.

    Following flap reflection, the bony defect will be examined carefully. Root planing is performed,. Flap closure will be performed by horizontal mattress sutures, placed 3 mm away from the borders, will be used as the first line of closure, promoting connective tissue contact between both edges of the incision, and single interrupted sutures will then be placed as a second line of closure. Using 5/0 polypropylene monofilament suture, Assut, Swiss

  • single-flap approach SFAProcedure or surgery

    As described by Trombelli et al 2010, A horizontal, butt-joint incision will be performed at the interdental papilla 1-2 mm coronal to the bone crest (as detected through pre-operative bone sounding).

    -A buccal mucoperiosteal envelope flap will be elevated by using a microsurgical periosteal elevator, leaving the residual portion of the interdental supracrestal soft tissues undetached.Flap closure will be performed by a horizontal internal mattress suture,will be performed at the base of the papilla, and a second internal mattress suture (vertical or horizontal) was performed between the most coronal portion of the flap and the most coronal portion of the palatal/lingual papilla. Using a resorbable suture

Study groups in NCT06003322
Study groupRoleWhat they receive
non - Incised Papilla surgical approach NIPSA for intrabony defectExperimentalGroup I will be allocated to non - Incised Papilla surgical approach NIPSA for intrabony defect with DBBM and PRF
Receives: Procedure: non - Incised Papilla surgical approach NIPSA for intrabony defect
single-flap approachActive comparatorgroup II will be allocated to single-flap approach SFA for intrabony defect with DBBM and PRF
Receives: Procedure: single-flap approach SFA

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. interproximal clinical attachment level change

    CAL, measured in the interproximal space from the CEJ to the base of the pocket(BP)using a millimeter periodontal probe

    Measured: at baseline ,6 and 12 months

Secondary outcomes (1)
  1. residual probing pocket depth (PPD), pocket depth (PD) change,

    -Inter- proximal PD, measured in the interproximal space from the gingival margin to the BP measured by a millimeter periodontal probe

    Measured: at at baseline ,6 and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Aug 2023
  2. Study start7 Aug 2023
  3. Primary completion7 Aug 2024 (estimated)
  4. Study completion7 Sep 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Care provider, Outcomes assessor
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06003322
Sponsor's protocol ID
PER243
Status last verified
Aug 2023
First submitted
24 Jun 2023
Last updated
21 Aug 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing non - Incised Papilla surgical approach NIPSA for intrabony defect and single-flap approach SFA in people with Periodontal Attachment Loss, run by Ain Shams University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Alaa Ali, P.h.D (01003646556, alaa.ali@dent.aun.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

interproximal clinical attachment level change (time frame: at baseline ,6 and 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in